We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

1 hedge funds and large institutions have $2.06K invested in Nymox Pharmaceutical Corp in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

50% less capital invested

Capital invested by funds: $4.13K → $2.06K (-$2.08K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NYMX Hedge Fund Activity: Q3 2025 in Review

1 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2025, worth a combined $2.06K — down 50% from $4.13K a quarter earlier.

Fund positioning in NYMX was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Nymox Pharmaceutical Corp (NYMX) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $2.06K of Nymox Pharmaceutical Corp stock for Q3 2025, down 50% quarter-over-quarter.
  • 0 funds opened new Nymox Pharmaceutical Corp positions in Q3 2025 and 0 closed out.

Based on aggregated 13F filings for Q3 2025.